21 results
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management ... - ACR/VF 2021 Guidelines ... for Treatment & ... #Management #Treatment ... #ACR2021 #Guidelines
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
Nodosa (PAN) - Vasculitis ... Management Algorithm - ACR ... /VF 2021 Guidelines ... #Management #Treatment ... #ACR2021 #Guidelines
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Polyangiitis (MPA) - ANCA Vasculitis ... Management Algorithm - ACR ... /VF 2021 Guidelines ... #Management #Treatment ... #ACR2021 #Guidelines
Summary of meta-analysis of pharmacotherapy trials in BPD
https://www.cochrane.org/CD005652/BEHAV_psychological-therapies-borderline-personality-disorder
Meta-analyses of RCTs were undertaken for the following outcomes:
with ‘treatment ... for inclusion all ... summarised in Tables ... EBM #Management #Pharmacology ... Effectiveness #Table
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
(EGPA) - ANCA Vasculitis ... Management Algorithm - ACR ... /VF 2021 Guidelines ... #Management #Treatment ... #ACR2021 #Guidelines
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Arteritis (GCA) - Vasculitis ... Management Algorithm - ACR ... /VF 2021 Guidelines ... #Management #Treatment ... #ACR2021 #Guidelines
Medications Used in Hypertensive Emergencies
Vasodilators: Hydralazine, Nitroglycerin, Sodium nitroprusside 
Calcium Channel Blockers: Clevidipine, Nicardipine
ß-Blockers: Esmolol, Labetalol,
Labetalol, Metoprolol ACE ... Medications #Management #Treatment ... #Pharmacology # ... Table
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... recommended by the ACC ... /AHA guidelines. ... HeartFailure #HFrEF #Pharmacology ... #Management #Treatment
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Inhibitor GOLD 2019 Guideline ... Dosing: 250 mcg tablet ... 2019 COPD GOLD guidelines ... recommendations for the treatment ... #Indications #Pharmacology
Natural history
Aneurysms may progress in size as a result of gradual wall weakening [6], with rupture
cm in men [7] (Table ... Table 1: Annual ... Brewster DC et al ... . (2003) Guidelines ... for the treatment